p16 post-hoc analyses and Simpson's paradox.
1st Department of Otolaryngology-Head & Neck Surgery, Aristotle University of Thessaloniki, Thessaloniki, Greece. Electronic address: akyrgidi@gmail.com.
Athanassios
A
Kyrgidis
Department of Clinical Pharmacology, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Thrasivoulos-George
TG
Tzellos
Hospital for Skin and Venereal Diseases, Thessaloniki, Greece.
Anastasia
A
Trigoni
Department of Clinical Pharmacology, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Stefanos
S
Triaridis
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000032:analysis*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy* / Q000378:metabolism / Q000401:mortality; D002986:Clinical Trials as Topic; D019941:Cyclin-Dependent Kinase Inhibitor p16; D018450:Disease Progression; D006258:Head and Neck Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000401:mortality; D006801:Humans; D009363:Neoplasm Proteins / Q000378:metabolism*; D011379:Prognosis; D015996:Survival Rate
D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; C000614131:CDKN2A protein, human; D019941:Cyclin-Dependent Kinase Inhibitor p16; D009363:Neoplasm Proteins